Johnson & Johnson spent a whopping $28.4 million in 2015 for fees, meals, travel, gifts and royalties – but not research – to health care providers for promotional speeches or consultation involving its top selling anticoagulant Xarelto, according to Propublicae’s updated Dollars for Docs database. It was the highest amount paid by a drug company in 2015 for so-called “general payments” to doctors to promote their meds. Pfizer and Bristol-Myers Squibb’s similar blood thinner, Eliquis, is poised to steal Xarelto’s large share of the blood thinner market. Its makers shelled out $18.8 million in general payments to doctors to help ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.